|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2011-8-23
|
|
pubmed:abstractText |
Although Brevibacterium species used to be considered as nonpathogenic microorganisms until recently, it seems that they can cause a wide variety of clinical diseases by acting mostly as opportunistic pathogens. The present case is the second reported case of infective endocarditis by Brevibacterium species; however, it is the first reported infected native aortic valve in an immunocompetent patient.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1538-2990
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
342
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
257-8
|
|
pubmed:meshHeading |
pubmed-meshheading:21681068-Actinomycetales Infections,
pubmed-meshheading:21681068-Anti-Bacterial Agents,
pubmed-meshheading:21681068-Aortic Valve,
pubmed-meshheading:21681068-Brevibacterium,
pubmed-meshheading:21681068-Drug Therapy, Combination,
pubmed-meshheading:21681068-Endocarditis, Bacterial,
pubmed-meshheading:21681068-Gentamicins,
pubmed-meshheading:21681068-Heart Valve Diseases,
pubmed-meshheading:21681068-Humans,
pubmed-meshheading:21681068-Immunocompetence,
pubmed-meshheading:21681068-Male,
pubmed-meshheading:21681068-Middle Aged,
pubmed-meshheading:21681068-Vancomycin
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Native aortic valve endocarditis caused by Brevibacterium epidermidis in an immunocompetent patient.
|
|
pubmed:affiliation |
Department of Cardiology, Asklepeion General Hospital, Athens, Greece.
|
|
pubmed:publicationType |
Journal Article,
Case Reports,
Research Support, Non-U.S. Gov't
|
